Immediate Impact
54 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Cross-priming in cancer immunology and immunotherapy
2025 Standout
Works of Arash Soltani being referenced
Recent advances in the clinical development of immune checkpoint blockade therapy
2019
PD-1/ PD-L1 blockade as a novel treatment for colorectal cancer
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Arash Soltani | 529 | 323 | 438 | 31 | 1.2k | |
| Xiaoping Wang | 546 | 303 | 404 | 45 | 1.3k | |
| Yan Tian | 579 | 236 | 438 | 35 | 1.4k | |
| Yan Du | 631 | 313 | 316 | 53 | 1.4k | |
| Atieh Pourbagheri‐Sigaroodi | 603 | 269 | 258 | 56 | 1.3k | |
| He Li | 730 | 259 | 479 | 40 | 1.3k | |
| Chiara Focaccetti | 482 | 576 | 474 | 41 | 1.4k | |
| Kasturi Banerjee | 582 | 253 | 420 | 28 | 1.2k | |
| Heriberto Prado-Garcı́a | 730 | 339 | 387 | 46 | 1.5k | |
| Divya Singh | 575 | 661 | 518 | 41 | 1.7k | |
| Zahra Asadzadeh | 647 | 450 | 562 | 44 | 1.6k |
All Works
Login with ORCID to disown or claim papers
Loading papers...